Login / Signup

Three-year clinical course after fluoropolymer-based drug-eluting stent implantation for femoropopliteal lesions.

Osamu IidaMitsuyoshi TakaharaYoshimitsu SogaTerutoshi YamaokaMasahiko FujiharaDaizo KawasakiShigeo IchihashiYasushi SakataToshiaki ManoYoshiharu Higuchi
Published in: Vascular medicine (London, England) (2024)
This study highlights the favorable long-term clinical course of FP-DES in real-world practice, emphasizing the importance of monitoring for occlusive restenosis and stent thrombosis while considering the potential onset of aneurysmal degeneration.
Keyphrases
  • primary care
  • healthcare
  • pulmonary embolism
  • sickle cell disease
  • quality improvement